Diagnostic Imaging's A Look Ahead: Feb. 1, 2021, to Feb. 5, 2021
Here's what to expect this week on Diagnostic Imaging.
In this week’s preview, here are some highlights of what you can expect to see coming soon:
The COVID-19 pandemic has made already difficult purchasing decisions even harder for many organizations. Is it possible for organizations to hit the sweet spot in investing in new technologies and controlling costs? This week, Guido Stoeckmann, regional sales manager for Dunlee, a medical imaging components manufacturer, offers guidance on how you can – and should – re-define your imaging technology investments. Look for his column later this week.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
Recent conversations around low-dose CT screening for lung cancer have pointed out its low participation rates and discussed its efficacy. This week, however, in research presented at the 2021 World Conference on Lung Cancer, investigators from Taiwan are sharing their results on the performance of the screening in a never-smoker population. Look for our coverage of their encouraging results later this week.
For additional low-dose CT screening coverage, click here.
Treatments for prostate cancer, such as surgery or radiation therapy, are effective, but they often bring unwanted side effects. This week, in Radiology, investigators will share the outcomes of their work with a different technique that can be used to treat intermediate-risk prostate cancer. Keep your eyes open for details about their study.
For additional coverage of prostate cancer, click here.
Breast MRI and Background Parenchymal Enhancement: What a Meta-Analysis Reveals
May 29th 2025Moderate or marked background parenchymal enhancement (BPE) reduces the sensitivity and specificity of MRI for breast cancer detection by more than 10 percent in comparison to scans with minimal or mild BPE, according to a new meta-analysis.
Photon-Counting Computed Tomography: Eleven Takeaways from a New Literature Review
May 27th 2025In a review of 155 studies, researchers examined the capabilities of photon-counting computed tomography (PCCT) for enhanced accuracy, tissue characterization, artifact reduction and reduced radiation dosing across thoracic, abdominal, and cardiothoracic imaging applications.
Can a Six-Minute MRI Facilitate Detection of Multiple Sclerosis?
May 23rd 2025Recognition of the central vein sign with a six-minute MRI demonstrated comparable sensitivity for multiple sclerosis (MS) detection in comparison to oligoclonal band (OCB) assessment, which requires lumbar puncture, according to newly published research.
